Submitted by Anonymous (not verified) on 27 September 2023 - 10:47
Human medicines European public assessment report (EPAR): Sovaldi, sofosbuvir, Hepatitis C, Chronic, Date of authorisation: 16/01/2014, Revision: 28, Status: Authorised
Source: